MedPath

Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation

Not Applicable
Terminated
Conditions
Atrial Fibrillation
Registration Number
NCT00528307
Lead Sponsor
R&D Cardiologie
Brief Summary

To determine whether Biventricular pacing in patients undergoing HIS bundle ablation for atrial fibrilation has beneficial effects on myocardial perfusion and left ventricularr ejection fraction.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Normal to nearly normal LVF (EF > 40%)
  • Drug-refractory, persistent or permanent atrial fibrillation
  • Referred for His ablation
Exclusion Criteria
  • Unwilling or unable to sign the informed consent
  • Life expectancy < 1year from non-cardiac causes
  • Previous myocardial infarction
  • Previous coronary bypass surgery
  • Poor left ventricle function (EF< 40%) from any cause
  • Symptomatic obstructive coronary artery disease
  • Poor ultra sound imaging quality.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Difference in size of myocardial perfusion abnormalities in the two treatment groups as measured with MPS.6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St Antonius Hospital

🇳🇱

Nieuwegein, Utrecht, Netherlands

St Antonius Hospital
🇳🇱Nieuwegein, Utrecht, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.